China Flow Cytometry Market Size & Outlook, 2024-2030
China flow cytometry market, 2018-2030 (US$M)
Related Markets
China flow cytometry market highlights
- The China flow cytometry market generated a revenue of USD 339.7 million in 2024 and is expected to reach USD 590.5 million by 2030.
- The China market is expected to grow at a CAGR of 9.7% from 2025 to 2030.
- In terms of segment, instruments was the largest revenue generating product in 2024.
- Software is the most lucrative product segment registering the fastest growth during the forecast period.
Flow cytometry market data book summary
| Market revenue in 2024 | USD 339.7 million |
| Market revenue in 2030 | USD 590.5 million |
| Growth rate | 9.7% (CAGR from 2025 to 2030) |
| Largest segment | Instruments |
| Fastest growing segment | Software |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Reagents & Consumables, Software, Accessories, Services |
| Key market players worldwide | Danaher Corp, BD, Sysmex Corp, Agilent Technologies, Apogee Enterprises Inc, Bio-Rad Laboratories Inc Class A, Thermo Fisher Scientific Inc, Wipro Ltd ADR, Diasorin SpA, Miltenyi Biotec, Sony Group Corp |
Other key industry trends
- In terms of revenue, China accounted for 7.3% of the global flow cytometry market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China flow cytometry market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 590.5 million by 2030.
Instruments was the largest segment with a revenue share of 40.45% in 2024. Horizon Databook has segmented the China flow cytometry market based on instruments, reagents & consumables, software, accessories, services covering the revenue growth of each sub-segment from 2018 to 2030.
The flow cytometry market in China is expected to grow at a lucrative rate during the forecast period. This fast growth can be attributed to the robust growth of pharmaceutical, biotechnology, and biopharmaceutical sectors in China.
In 2019, the Beijing Xisike Clinical Oncology Research Foundation granted funds to support the expansion of clinical and scientific research in China. In addition, extensive research activities have been conducted by several Chinese pharmaceutical companies for the development of novel vaccines or therapies for COVID-19.
Increased R&D initiatives are anticipated to significantly boost the demand for flow cytometry products in the country, thus supporting market growth. Moreover, key players are undertaking both organic and inorganic growth strategies to gain a competitive edge in China flow cytometry market.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Flow Cytometry Market Scope
Flow Cytometry Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China flow cytometry market size, by product, 2018-2030 (US$M)
China Flow Cytometry Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
